The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2023 | Oneill Alison | Chief Medical Officer | Disposed to issuer(D) | 57K | — | — |
| Sep 8, 2023 | Oneill Alison | Chief Medical Officer | Disposed to issuer(D) | 150K | — | $0 |
| Sep 8, 2023 | Grayzel David S. | Director | Disposed to issuer(D) | 2.9M | — | — |
| Sep 8, 2023 | Ross Robert W. | Chief Executive Officer, Director | Disposed to issuer(D) | 83K | — | — |
| Sep 8, 2023 | Ross Robert W. | Chief Executive Officer, Director | Disposed to issuer(D) | 400K | — | $0 |
| Sep 8, 2023 | Goater Jeff | Director | Disposed to issuer(D) | 129K | — | — |
| Sep 8, 2023 | Rath Henry C. | Chief Business Officer | Disposed to issuer(D) | 45K | — | — |
| Sep 8, 2023 | Rath Henry C. | Chief Business Officer | Disposed to issuer(D) | 150K | — | $0 |
| Sep 8, 2023 | Adams Chandra | Deputy GC | Disposed to issuer(D) | 24K | — | — |
| Sep 8, 2023 | Adams Chandra | Deputy GC | Disposed to issuer(D) | 50K | — | $0 |
| Sep 8, 2023 | Adams Chandra | Deputy GC | Disposed to issuer(D) | 50K | — | $0 |
| Sep 8, 2023 | Sigal Charles Elliott | Director | Disposed to issuer(D) | 45K | — | — |
| Sep 8, 2023 | Sigal Charles Elliott | Director | Disposed to issuer(D) | 114K | — | $0 |
| Sep 8, 2023 | Fees Jessica | Chief Financial Officer | Disposed to issuer(D) | 102K | — | — |
| Sep 8, 2023 | Fees Jessica | Chief Financial Officer | Disposed to issuer(D) | 150K | — | $0 |
| Sep 8, 2023 | Palombella Vito J. | Chief Scientific Officer | Disposed to issuer(D) | 87K | — | — |
| Sep 8, 2023 | Palombella Vito J. | Chief Scientific Officer | Disposed to issuer(D) | 150K | — | $0 |
| Aug 1, 2023 | Ross Robert W. | Chief Executive Officer | Sell(S) | 17K | $0.94 | $16K |
| Aug 1, 2023 | Fees Jessica | Chief Financial Officer | Sell(S) | 9K | $0.94 | $9K |
| Aug 1, 2023 | Adams Chandra | Deputy GC | Sell(S) | 4K | $0.94 | $4K |
| Aug 1, 2023 | Oneill Alison | Chief Medical Officer | Sell(S) | 7K | $0.94 | $7K |
| Mar 1, 2023 | Palombella Vito J. | Chief Scientific Officer | Grant(A) | 150K | — | $0 |
| Mar 1, 2023 | Fees Jessica | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Mar 1, 2023 | Oneill Alison | Chief Medical Officer | Grant(A) | 150K | — | $0 |
| Mar 1, 2023 | Adams Chandra | Deputy GC | Grant(A) | 50K | — | $0 |
| Mar 1, 2023 | Adams Chandra | Deputy GC | Grant(A) | 50K | — | $0 |
| Mar 1, 2023 | Ross Robert W. | Chief Executive Officer | Grant(A) | 400K | — | $0 |
| Mar 1, 2023 | Rath Henry C. | Chief Business Officer | Grant(A) | 150K | — | $0 |
| Nov 1, 2022 | Adams Chandra | Deputy GC | Grant(A) | 30K | — | $0 |
| Aug 3, 2022 | Palombella Vito J. | Chief Scientific Officer | Sell(S) | 4K | $1.72 | $8K |
| Aug 3, 2022 | Fees Jessica | Chief Financial Officer | Sell(S) | 6K | $1.72 | $10K |
| Aug 3, 2022 | Ross Robert W. | Chief Executive Officer | Sell(S) | 11K | $1.72 | $18K |
| Aug 3, 2022 | Oneill Alison | Chief Medical Officer | Sell(S) | 4K | $1.72 | $8K |
| Aug 3, 2022 | Rath Henry C. | Chief Business Officer | Sell(S) | 6K | $1.72 | $10K |
| Jun 28, 2022 | Brunn Carsten | Director | Grant(A) | 48K | — | $0 |
| Jun 8, 2022 | Goater Jeff | Director | Grant(A) | 24K | — | $0 |
| Jun 8, 2022 | Grayzel David S. | Director | Grant(A) | 24K | — | $0 |
| Jun 8, 2022 | Ibrahim Ramy | Director | Grant(A) | 24K | — | $0 |
| Jun 8, 2022 | Hickey Benjamin | Director | Grant(A) | 24K | — | $0 |
| Jun 8, 2022 | Stelzer Laurie | Director | Grant(A) | 24K | — | $0 |
| Jun 8, 2022 | Torres Denice | Director | Grant(A) | 24K | — | $0 |
| Jun 8, 2022 | Shanafelt Armen | Director, 10% Owner | Grant(A) | 24K | — | $0 |
| Jun 8, 2022 | Sigal Charles Elliott | Director | Grant(A) | 24K | — | $0 |
| Apr 1, 2022 | Boni Theresa | General Counsel & Secretary | Grant(A) | 120K | — | $0 |
| Mar 1, 2022 | Palombella Vito J. | Chief Scientific Officer | Grant(A) | 38K | — | $0 |
| Mar 1, 2022 | Palombella Vito J. | Chief Scientific Officer | Grant(A) | 108K | — | $0 |
| Mar 1, 2022 | Oneill Alison | Chief Medical Officer | Grant(A) | 38K | — | $0 |
| Mar 1, 2022 | Oneill Alison | Chief Medical Officer | Grant(A) | 108K | — | $0 |
| Mar 1, 2022 | Fees Jessica | Chief Financial Officer | Grant(A) | 38K | — | $0 |
| Mar 1, 2022 | Fees Jessica | Chief Financial Officer | Grant(A) | 108K | — | $0 |
| Mar 1, 2022 | Rath Henry C. | Chief Business Officer | Grant(A) | 38K | — | $0 |
| Mar 1, 2022 | Rath Henry C. | Chief Business Officer | Grant(A) | 108K | — | $0 |
| Mar 1, 2022 | Ross Robert W. | Chief Executive Officer | Grant(A) | 56K | — | $0 |
| Mar 1, 2022 | Ross Robert W. | Chief Executive Officer | Grant(A) | 359K | — | $0 |
| Jan 3, 2022 | Torres Denice | Director | Grant(A) | 12K | — | $0 |
| Jan 3, 2022 | Hickey Benjamin | Director | Grant(A) | 24K | — | $0 |
| Aug 2, 2021 | Torres Denice | Director | Grant(A) | 36K | — | $0 |
| Jul 21, 2021 | Oneill Alison | Chief Medical Officer | Sell(S) | 15K | $6.10 | $90K |
| Jul 21, 2021 | Nogelo Liisa I | Chief Legal Officer | Sell(S) | 26K | $6.10 | $161K |
| Jul 21, 2021 | Ross Robert W. | Chief Executive Officer | Sell(S) | 34K | $6.10 | $204K |
| Jul 21, 2021 | Palombella Vito J. | Chief Scientific Officer | Sell(S) | 26K | $6.10 | $161K |
| Jul 21, 2021 | Fees Jessica | Chief Financial Officer | Sell(S) | 20K | $6.10 | $121K |
| Jul 21, 2021 | Goater Jeff | Director | Sell(S) | 128K | $6.10 | $779K |
| Jun 11, 2021 | Goater Jeff | Director | Option exercise(M) | 10K | — | $0 |
| Jun 11, 2021 | Goater Jeff | Director | Option exercise(M) | 10K | $4.14 | $43K |
| Jun 11, 2021 | Goater Jeff | Director | Sell(S) | 15K | $7.61 | $116K |
| Jun 10, 2021 | Goater Jeff | Director | Option exercise(M) | 200K | — | $0 |
| Jun 10, 2021 | Goater Jeff | Director | Option exercise(M) | 35K | — | $0 |
| Jun 10, 2021 | Goater Jeff | Director | Option exercise(M) | 35K | $4.14 | $144K |
| Jun 10, 2021 | Goater Jeff | Director | Option exercise(M) | 200K | $4.14 | $828K |
| Jun 10, 2021 | Goater Jeff | Director | Sell(S) | 235K | $7.66 | $1.8M |
| Jun 8, 2021 | McDonough Geoff | Director | Grant(A) | 18K | — | $0 |
| Jun 8, 2021 | Shanafelt Armen | Director, 10% Owner | Grant(A) | 18K | — | $0 |
| Jun 8, 2021 | Ibrahim Ramy | Director | Grant(A) | 18K | — | $0 |
| Jun 8, 2021 | Stelzer Laurie | Director | Grant(A) | 18K | — | $0 |
| Jun 8, 2021 | Grayzel David S. | Director | Grant(A) | 18K | — | $0 |
| Jun 8, 2021 | Sigal Charles Elliott | Director | Grant(A) | 18K | — | $0 |
| May 3, 2021 | Fees Jessica | See Remarks | Grant(A) | 30K | — | $0 |
| May 3, 2021 | Rath Henry C. | Chief Business Officer | Grant(A) | 140K | — | $0 |
| May 3, 2021 | Oneill Alison | CHIEF MEDICAL OFFICER | Grant(A) | 30K | — | $0 |
| Apr 1, 2021 | Goater Jeff | Director | Grant(A) | 4K | — | $0 |
| Apr 1, 2021 | Goater Jeff | Director | Grant(A) | 35K | — | $0 |
| Apr 1, 2021 | Goater Jeff | Director | Grant(A) | 15K | — | $0 |
| Apr 1, 2021 | Goater Jeff | Director | Grant(A) | 15K | — | $0 |
| Mar 1, 2020 | Oneill Alison | Chief Medical Officer | Grant(A) | 45K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).